CLINICAL SIGNIFICANCE OF UPPER AIRWAYS' LATENT INFECTION'S INFLUENCE FOR THE COURSE OF BRONCHIAL ASTHMA IN CHILDREN
https://doi.org/10.15690/pf.v9i6.519
Abstract
The study was based on the examination of 100 children (71 boy and 29 girls) aged 3–18 years with bronchial asthma in remission. The routine allergological examination was followed up by the immunohistochemical test of deep pharyngeal mucosal cells samples scraped to verify the Chlamydia pneumoniae, Cytomegalovirus hominis, HSV-1, HSV-2, EBV as well as by the bacterioscopic examination of pharyngeal causative and opportunistic pathogens. The immunological examination included evaluation of lymphocyte subpopulation (CD 3+, CD3+CD(16+56+)+ TNK cells, T helpers (CD3+CD4+), double-positive cells (CD4+CD8+), CD3-CD(16+56)+NK cells by means of flow cytometry. Measurements of spontaneous and induced cytokine production (IFN α, IFN γ, IL 4) were taken using the immune assay. The level of specific antibodies (Ig M, Ig G) to the relevant infectious agents in the serum was measured as well. These examinations demonstrated that children with bronchial asthma and latent infection of the upper respiratory tract have higher rates of bronchial hyperreactivity (86%) as well as more frequent (74,7%) uncontrolled or partially controlled course of asthma. According to the examination results, in children with broncial asthma and latent infection of the upper respiratory tract α-interferon induction is oppressed (74,7%), the IL4 in the serum is increased along with a shift of the immune response towards Th2, cytotoxic response is increased, TNK cells are increased (75,5%) with simultaneous decrease of NK cells.
About the Authors
N. A. Sukhanova
Saint Petersburg State Pediatric Medical Academy, Russian Federation
Russian Federation
Russian Federation
E. A. Tsvetkov
Saint Petersburg State Pediatric Medical Academy, Russian Federation
Russian Federation
Russian Federation
G. A. Novik
Saint Petersburg State Pediatric Medical Academy, Russian Federation
Russian Federation
Russian Federation
References
1. Rose M. A., Schubert R., Schmitt-Grohe S., Reichenbach J., Zielen S. Immunoglobulins and inflammatory cytokines in nasal secretions in humoral immunodeficiencies. Laryngoscope. 2006; 116 (2): 239–244.
2. Miller E. K., Griffin M. R., Edwards K. M., Weinberg G. A., Szilagyi P. G., Staat M. A., Zhu Y., Hall C. B., Fairbrother G., Seither R., Erdman D., Lu P., Poehling K. A. New Vaccine Surveillance Network. Influenza burden for children with asthma. Pediatrics. 2008; 121 (1): 1–8.
3. Steele C., Fidel P. L. Cytokine and chemocine production by human oral and vaginal epithelial cells in response to Candida albicans. Infec Immun. 2002; 70 (2): 577–583.
4. Аллергология и иммунология. Под ред. А. А. Баранова и Р. М. Хаитова. Союз педиатров России. 2011; 3: 24.
5. Новик Г. А. Бронхиальная астма у детей. Под ред. И. М. Воронцова. СПб.: Фолиант. 2009. 230 с.
6. Bacharier L. B., Boner A., Carlsen K.-H., Eigenmann P. A., Frischer T., Gotz M., Helms P. J., Hunt J., Liu A., Papadopoulos N., Platts-Mills T., Pohunek P., Simons F. E., Valovirta E., Wahn U., Wildhaber J. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy. 2008; 63 (1): 5–34.
7. Gern J.E., Lemanske R. F. Infectious trIggers of pediatric asthma. Pediatr Clin North Am. 2003; 50 (3): 555–575. 8. Огородова Л. М. Тяжелая БА у детей. Consilium Medicum. 2001; 3 (9): 9–25.
8. Зайцева О. В. Бронхиальная астма и респираторные инфекции у детей. Пульмонология. 2007; 4: 106–111.
9. Харламова Ф. С. Вирусы семейства герпеса и иммунитет. Под ред. Ф. С. Харламова, Н. Ю. Егорова, Л. Н. Гусева и др. Детские инфекции: Науч.-практ. журн. ассоц. педиатров-инфекционистов. 2006; 5 (3): 3–10.
10. Романенко Э. Е. Сравнительная характеристика микрофлоры слизистых верхних дыхательных путей при бронхиальной астме и персистирующем аллергическом рините. Под ред. Э. Е. Романенко, А. П. Батуро, И. Н. Улиско. Журнал микробиологии, эпидемиологии и иммунобиологии. 2005; 2: 61–65.
11. Gern J. E. Mechanism of virus- induced asthma. J Pediatr. 2003; 142: 9–14.
12. Gern J. E. Viral respiratory infection and the link to asthma. Pediatr Infect Dis. 2008; 27: 97–103.
13. Учайкин В. Ф. Решенные и нерешенные проблемы инфекционной патологии у детей. Педиатрия. 2004; 4: 7–10.
14. Калинина Н. М., Давыдова Н. И. Роль иммунотропной терапии в повышении эффективности лечения герпес-вирусных инфекций. Terra medica nova: Всероссийский журнал для врачей всех специальностей. 2009; 1: 17–22.
15. Быков А. С., Воробьев А. А., Зверев В. В. Атлас по медицинской микробиологии, вирусологии и иммунологии. Медицинское информационное агентство. 2008. 272 с.
16. Рабсон А. Основы медицинской иммунологии: пер. с англ. под ред. А. Рабсон, А. Ройт, П. Делвз. М.: Мир. 2006. 320 с.
17. Cohen J. I. EBV RARF-1 protein is dispensable for B cell transpormation in inhibites LiNF Secretion from mononuclear cells. J Virol. 1999; 73: 7623–7632.
18. Haas H., Falcone F. H., Holland M. J. et al. Early IL-4: its role in the switch towards a Th2 response and Ig E- mediated allergy. Int Arch Allergy Immunol. 1999; 119: 86–94.
19. Sears M. R. Epidemiology of asthma exacerbations. Allergy Clin Immunol. 2008; 122 (4): 662–670.
Review
For citations:
Sukhanova N.A., Tsvetkov E.A., Novik G.A. CLINICAL SIGNIFICANCE OF UPPER AIRWAYS' LATENT INFECTION'S INFLUENCE FOR THE COURSE OF BRONCHIAL ASTHMA IN CHILDREN. Pediatric pharmacology. 2012;9(6):54-60. (In Russ.) https://doi.org/10.15690/pf.v9i6.519
Views:
788
Email this article 